Camera outside the Los Olmos Retirement Home on the day Araceli and Monica, the longest-serving resident of the Los Olmos Retirement Home and the youngest health care worker, receive their second dose of the Pfizer-BioNTech vaccine in Guadalajara, Castilla-La Mancha (Spain), January 18, 2021. Araceli Rosario Hidalgo, an intern at Los Olmos nursing home in Guadalajara since 2013 and born in 1924, and Monica Tapias, born in 1972, an auxiliary nurse care technician (TCAE) who has been working at the centre for ten years, were the first two people to receive the COVID-19 vaccine in Spain and today they have received the second dose. 18 JANUARY 2021;CORONAVIRUS VACCINATION;SECOND DOSE RAFAEL MARTÃN LagenciaEP 01 18 2021 Guadalajara (Castill
Choose your license
Rights Managed:
One-time editorial use in an online article, social media channels, internal presentation, website, newsletter, or blog.
One-time editorial use in a book, newspaper or magazine (excluding cover page), external presentation. Limited to 5,000 circulation. This includes the rights available in the Standard license.
Media Info
Credit: Lagencia
Media ID:
Recording Date: Jan 18, 2021
Media Size: 5,535×3,572 Pixels
Camera outside the Los Olmos Retirement Home on the day Araceli and Monica, the longest-serving resident of the Los Olmos Retirement Home and the youngest health care worker, receive their second dose of the Pfizer-BioNTech vaccine in Guadalajara, Castilla-La Mancha (Spain), January 18, 2021. Araceli Rosario Hidalgo, an intern at Los Olmos nursing home in Guadalajara since 2013 and born in 1924, and Monica Tapias, born in 1972, an auxiliary nurse care technician (TCAE) who has been working at the centre for ten years, were the first two people to receive the COVID-19 vaccine in Spain and today they have received the second dose. 18 JANUARY 2021;CORONAVIRUS VACCINATION;SECOND DOSE RAFAEL MARTÃN LagenciaEP 01 18 2021 Guadalajara (Castill
Release Info: Do I need a release?
Captions may have been translated or enriched by an AI system.
For more information about AI-assisted captions, see AI-assisted captions.
Need a custom license?
If your intended use isn't covered by the available options (such as non-editorial purposes or specific distribution needs), contact us. Our team will be happy to provide a tailored offer based on your requirements.
